heart

Widely used heart drug increases risk of death

Monday, December 24, 2012 by: David Gutierrez, staff writer
Tags: heart drugs, death risk, digoxin

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
CDC issues flu vaccine apology: this year's vaccine doesn't work!
Depopulation test run? 75% of children who received vaccines in Mexican town now dead or hospitalized
Biologist explains how marijuana causes tumor cells to commit suicide
Companies begin planting microchips under employees' skin
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
U2's Bono partners with Monsanto to destroy African agriculture with GMOs
NJ cops bust teenagers shoveling snow without a permit
Russia throws down the gauntlet: energy supply to Europe cut off; petrodollar abandoned as currency war escalates
McDonald's in global profit free fall as people everywhere increasingly reject chemically-altered toxic fast food
March Against Monsanto explodes globally... World citizens stage massive protests across 38 countries, 428 cities... mainstream media pretends it never happened
Chemotherapy kills cancer patients faster than no treatment at all
Why flu shots are the greatest medical fraud in history
600 strains of an aerosolized thought control vaccine already tested on humans; deployed via air, food and water
Italian court rules mercury and aluminum in vaccines cause autism: US media continues total blackout of medical truth
Flu vaccine kills 13 in Italy; death toll rises
The 21 curious questions we're never allowed to ask about vaccines
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Whooping cough outbreak at Massachusetts high school affected only vaccinated students

Delicious
(NaturalNews) A widely used heart drug actually increases the risk of death in patients with the very condition it is most commonly used to treat, according to a study conducted by researchers from the University of Kentucky and published in the European Heart Journal.

Digoxin, extracted from the foxglove plant, has been used as a treatment for heart disease for hundreds of years. The drug's ability to make the heart beat more strongly and regularly is well documented, making it a popular treatment for both atrial fibrillation (AF) and heart failure.

AF is characterized by an irregular heartbeat, also known as cardiac arrhythmia.

Although digoxin is widely used, it is also known to be dangerous. It is only effective within a very narrow dosage range, and high blood levels of the drug are known to be correlated with an increased rate of death. Until the current study; however, very little research has been conducted on the risks of digoxin use by patients with AF.

"Digoxin in AF patients has hardly been studied," lead researcher Samy Claude Elayi said. "The main prospective randomized controlled trials available with digoxin were performed in patients with heart failure and sinus rhythm, excluding AF patients."

"Our study underscores the importance of reassessing the role of digoxin in the contemporary management of AF in patients with or without [heart failure]," the researchers wrote.

Dramatic increase in deaths

The researchers analyzed data on 4,060 participants in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) trial, finding that AF patients who took digoxin were 41 percent more likely to die from any cause than AF patients who did not take the drug. This increased risk was found to be independent of other mortality correlates and risk factors, including gender, other medications and underlying heart failure. The researchers also found that digoxin patients were 35 percent more likely to die from cardiovascular causes, and 61 percent more likely to die from cardiac arrhythmia.

"These results mean that among AF patients taking digoxin compared to those not on digoxin in the AFFIRM trial, within five years one additional patient out of six will die from any cause, one additional patient out of eight will die from cardiovascular causes, and one additional patient out of 16 will die from arrhythmias," Elayi said.

"These findings call into question the widespread use of digoxin in patients with AF, particularly when used for controlling AF rate in a similar way as in the AFFIRM trial."

The findings suggest that doctors should attempt to control irregular heart rates using non-digoxin alternatives such as beta-blockers or calcium blockers whenever possible, Elayi said. In cases where the drug must be used, doctors should begin with a low dose and follow up carefully. The drug's levels should be monitored, and doctors should be especially cautious of interactions with other medications.

"Patients should be aware of potential toxicity and see their physicians immediately in specific clinical situations," Elayi said, "for instance if they experience palpitations or syncope, as those may precede arrhythmic death."

Sources:

http://www.eurekalert.org/pub_releases/2012-11/esoc-did112612.php

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.